Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-16 @ 1:04 AM
Study NCT ID:
NCT05053659
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2021-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
Sponsor:
Paolo Caimi, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-18
First Submit QC Date:
None
Study First Post Date:
2021-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL